THE UNIVERSITY of Queensland is seeking approval for human trials of a potential swine flu vaccine made using insect cells.
30/06/2009
COLLABORATION between the National Eye Institute (NEI) and NASA has produced a compact fibre-optic probe that has become the first non-invasive early detection device for cataracts.
15/01/2009
US scientists have discovered that the mosquito vector for malaria creates a barrier around the blood it ingests when taking a meal, thereby creating a safe 'haven' for the malaria parasite. Preventing this barrier from forming may be one strategy to stop the malaria from surviving while still in the mosquito's system, and thus stopping it from being passed on to humans.
19/03/2010
PERKINELMER has announced the release of 16 G-protein coupled receptor (GPCR) and ion channel cell lines which increase the company’s cell line portfolio to over 300.
05/05/2009
US scientists have identified three kinases, or proteins, that dismantle connections within brain cells, which may lead to memory loss associated with Alzheimer’s disease.
24/02/2010
SUPELCO has announced its HybridSPE-Precipitation technology has been awarded the SelectScience.net 2009 Scientists' Choice Award for Best New Separations Product in 2008.
16/04/2009
Researchers at the University of Sydney's Centenary Institute have made an exciting discovery that could lead to the first new drug for tuberculosis (TB) in almost 50 years.
31/03/2010
Melbourne researchers believe that the toxicity of amyloid plaques found in the brains of people with Alzheimer’s is related to trapping essential zinc, which is needed for communication between brain cells.
24/02/2010
US researchers have created synthetic molecules that enhance the body’s immune response to the AIDS virus (HIV) and HIV-infected cells. These synthetic molecules could lead to novel therapeutic approaches for AIDS patients.
12/11/2009
US researchers have discovered that a drug currently used for treating Alzheimer's can either improve or worsen the progression of Huntington's disease (HD) depending on where the brain cells it targets are located.
17/11/2009
Roche has announced the latest results of its Phase III clinical trial, CLL8, involving MabThera/Rituxan. The study compared MabThera/Rituxan with two different chemotherapy regimens as first-line treatment of patients with advanced follicular, indolent and mantle cell lymphomas.
10/12/2009
Roche has announced results from studies showing that Herceptin reduces the risk of the cancer returning by about one third in women with HER2-positive early breast cancer compared to patients receiving chemotherapy alone.
17/12/2009
Early trial results of a new candidate malaria vaccine has shown that young children in Mali produce strong and long-lasting immune responses. The vaccine was also seen be safe and well tolerated.
11/03/2010
Australian researchers have provided new insights into how loss of structure in regions of the brain may be associated with Alzheimer's Disease.
20/04/2010
Bayer has begun a clinical Phase I study to treat non-Hodgkins lymphoma (NHL) using a patient-specific vaccine derived from tobacco plants.
12/02/2010